Grantham, Mayo, Van Otterloo & Co (GMO)’s CR Bard Inc. BCR Stock Holding History
Bought
Maintained
Sold
Other funds holding BCR
GCIA
MSE
GF
AGM
CWM
BS
QCMA
AAF
Grantham, Mayo, Van Otterloo & Co (GMO)'s BCR Position: Q4 2017 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CR Bard Inc. (BCR) in Q4 2017, closing a stake of 196,200 shares — an estimated $62.9M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCR in Q2 2013 and held it in 17 quarters. The position peaked at $117M in Q2 2017. 111 funds tracked by Wall St. Rank hold BCR as of Q4 2017.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CR Bard Inc. position as of Q4 2017 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 196,200 CR Bard Inc. shares in Q4 2017, an estimated $62.9M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CR Bard Inc. in Q2 2013 and held it in 17 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s CR Bard Inc. position peaked at $117M in Q2 2017.
- 111 funds tracked by Wall St. Rank held CR Bard Inc. as of Q4 2017.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.